Osteopore Share Price and Company Fundamentals
Last traded: Last Monday at 10:59 PM
Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Taiwan, Indonesia, the Netherlands, the United Arab Emirates, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. It manufactures and trades medical implants and medical devices; and provides technology services, as well as engages in research and experimental development on biotechnology and medical science. Osteopore Limited was founded in 2003 and is headquartered in Singapore.
Key Metrics
PE ratio
-
PB ratio
-
Dividend yield
0.00%
Beta
0.01
Market cap
$2.08M
Enterprise value
$3.53M
Company profile
| Industry / Sector | Medical Instruments & Supplies / Healthcare |
|---|---|
| Website | https://www.osteopore.com |
| Mailing address | 2 Tukang Innovation Grove #09-06/07 JTC MedTech Hub Singapore 618305 Singapore |
| Phone / Fax | / |
Dividends
More: Osteopore Dividend history, yield and payout ratio
Dividend yield
0.00%
Dividend amount
$-
Payout ratio
-
5Y Avg. yield
-%
Osteopore paid $- dividend and the ex-dividend date was -.The dividend payout ratio is -. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.
Company Executives
As of Nov 2026, following are the company executives and directors listed on Osteopore.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Kei Wei Leong | Executive Chairman | 49 | |
| Dr. Yujing Lim Ph.D. | CEO, CTO & Executive Director | ||
| Ms. Shu Ning Voon | Group Financial Controller | ||
| Mr. Harry Miller | Company Secretary |
Profitability and management effectiveness
Profit margin
-135.81%
Operating margin
-118.62%
Return on assets
-57.24%
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Osteopore is 2.08M and its enterprise value is 3.53M. The enterprise value to revenue ratio of OSX is 1.21. The enterprise value to EBITDA ratio of OSX is -1.10.
The OSX's stocks Beta value is 0.01 making it 99% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Osteopore (OSX)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Pro Medicus (PME)
- Polynovo (PNV)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Osteopore (ASX:OSX) Frequently Asked Questions
1. What is Osteopore's Stock Symbol?
Osteopore trades on ASX under the ticker symbol "OSX".
2. What is Osteopore's stock price today?
One share of OSX stock can currently be purchased for approximately $0.003.
3. How can I contact Osteopore?
Osteopore's mailing address is 2 Tukang Innovation Grove #09-06/07 JTC MedTech Hub Singapore 618305 Singapore. The company can be reached via phone at .
4. What is Osteopore's official website?
The official website of Osteopore is https://www.osteopore.com.